Frontlight ResearchEarly access
Trial site
The University of Hong Kong/Queen Mary Hospital
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Atrial fibrillation2 trials
- Familial hypercholesterolaemia1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Haemophilia1 trial
- Heart failure1 trial
- Hepatitis B1 trial
- Liver and biliary tract cancer1 trial
- Liver cirrhosis1 trial
- Lung cancer1 trial
- Stroke1 trial
- Phase
- Phase 33 trials
- Phase 42 trials
- Status
- Active, not recruiting5 trials
- Completed1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Abbott Medical Devices2 trials
- The University of Hong Kong2 trials
- Baxalta now part of Shire1 trial
- Daiichi Sankyo1 trial
- Taiho Oncology, Inc.1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Familial hypercholesterolaemia1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026